{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:28:52Z","timestamp":1790494132359,"version":"4.1.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01264","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T05:35:11Z","timestamp":1592890511000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Characterization of Bacillus anthracis Spore Proteins Using a Nanoscaffold Vaccine Platform"],"prefix":"10.3389","volume":"11","author":[{"given":"Dina R.","family":"Weilhammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis D.","family":"Dunkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Boone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean F.","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Khemmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra K. G.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Hoeprich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas O.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"Blanchette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Driks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Rasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.2741\/3544","article-title":"Pathophysiology of anthrax","volume":"14","author":"Frankel","year":"2009","journal-title":"Front Biosci (Landmark Ed)."},{"key":"B2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.envint.2015.09.009","article-title":"Historical evolution of human anthrax from occupational disease to potentially global threat as bioweapon","volume":"85","author":"D'Amelio","year":"2015","journal-title":"Environ Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.12998\/wjcc.v3.i1.20","article-title":"Anthrax: a disease of biowarfare and public health importance","volume":"3","author":"Goel","year":"2015","journal-title":"World J Clin Cases."},{"key":"B4","first-page":"335","article-title":"Anthrax: clinical features, pathogenesis, and potential biological warfare threat","volume":"20","author":"Friedlander","year":"2000","journal-title":"Curr Clin Top Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","article-title":"Anthrax vaccine evidence for safety and efficacy against inhalational anthrax","volume":"282","author":"Friedlander","year":"1999","journal-title":"JAMA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2003.09.010","article-title":"Vaccines for the prevention of diseases caused by potential bioweapons","volume":"111","author":"Hassani","year":"2004","journal-title":"Clin Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","article-title":"In vitro correlate of immunity in an animal model of inhalational anthrax","volume":"87","author":"Pitt","year":"1999","journal-title":"J Appl Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.TBS-0021-2015","article-title":"The Bacillus anthracis exosporium: what's the big \u201cHairy\u201d deal?","volume":"3","author":"Bozue","year":"2015","journal-title":"Microbiol Spect."},{"key":"B10","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1128\/IAI.00884-07","article-title":"Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen","volume":"75","author":"Brahmbhatt","year":"2007","journal-title":"Infect Immun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/IAI.70.2.661-664.2002","article-title":"Anthrax spores make an essential contribution to vaccine efficacy","volume":"70","author":"Brossier","year":"2002","journal-title":"Infect Immun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1099\/jmm.0.045393-0","article-title":"Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia","volume":"61","author":"Cote","year":"2012","journal-title":"J Med Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1016\/j.vaccine.2008.07.015","article-title":"Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen","volume":"26","author":"Cybulski","year":"2008","journal-title":"Vaccine."},{"key":"B14","doi-asserted-by":"publisher","first-page":"10638","DOI":"10.1073\/pnas.1002348107","article-title":"Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax","volume":"107","author":"Datta","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1128\/IAI.01217-08","article-title":"Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax","volume":"77","author":"Gauthier","year":"2009","journal-title":"Infect Immun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1016\/j.vaccine.2005.08.031","article-title":"DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components","volume":"24","author":"Hahn","year":"2006","journal-title":"Vaccine."},{"key":"B17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"Reed","year":"2009","journal-title":"Trends Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1128\/CVI.00290-09","article-title":"Vaccines: the fourth century","volume":"16","author":"Plotkin","year":"2009","journal-title":"Clin Vaccine Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.4049\/jimmunol.175.4.2244","article-title":"Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves Type I IFN and stabilization of class I MHC mRNA","volume":"175","author":"Kuchtey","year":"2005","journal-title":"J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1365-2567.2005.02268.x","article-title":"Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles","volume":"117","author":"Shen","year":"2006","journal-title":"Immunology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e11643","DOI":"10.1371\/journal.pone.0011643","article-title":"Isolation, characterization, and stability of discretely-sized nanolipoprotein particles assembled with apolipophorin-III","volume":"5","author":"Fischer","year":"2010","journal-title":"PLoS One."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1021\/bc100083d","article-title":"Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis","volume":"21","author":"Fischer","year":"2010","journal-title":"Bioconjug Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1021\/ja3063293","article-title":"Colocalized delivery of adjuvant and antigen using nanolipoprotein particles enhances the immune response to recombinant antigens","volume":"135","author":"Fischer","year":"2013","journal-title":"J Am Chem Soc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e93342","DOI":"10.1371\/journal.pone.0093342","article-title":"Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platform","volume":"9","author":"Fischer","year":"2014","journal-title":"PLoS One."},{"key":"B27","doi-asserted-by":"publisher","first-page":"10305","DOI":"10.1016\/j.biomaterials.2013.09.038","article-title":"The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge","volume":"34","author":"Weilhammer","year":"2013","journal-title":"Biomaterials."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.vaccine.2017.02.004","article-title":"Enhancement of antigen-specific CD4+ and CD8+ T cell responses using a self-assembled biologic nanolipoprotein particle vaccine","volume":"35","author":"Weilhammer","year":"2017","journal-title":"Vaccine."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1128\/JB.185.6.1903-1910.2003","article-title":"Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium","volume":"185","author":"Steichen","year":"2003","journal-title":"J Bacteriol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell Mol Life Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.micpath.2011.06.005","article-title":"Binding of group B streptococcal phosphoglycerate kinase to plasminogen and actin","volume":"51","author":"Boone","year":"2011","journal-title":"Microb Pathog."},{"key":"B32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.pep.2005.09.027","article-title":"Single step protocol to purify recombinant proteins with low endotoxin contents","volume":"46","author":"Reichelt","year":"2006","journal-title":"Protein Expr Purif."},{"key":"B33","doi-asserted-by":"publisher","first-page":"14348","DOI":"10.1021\/ja074753y","article-title":"Different apolipoproteins impact nanolipoprotein particle formation","volume":"129","author":"Chromy","year":"2007","journal-title":"J Am Chem Soc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bbrc.2012.04.007","article-title":"Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice","volume":"421","author":"Uchida","year":"2012","journal-title":"Biochem Biophys Res Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1021\/bc100129s","article-title":"Kinetic analysis of his-tagged protein binding to nickel-chelating nanolipoprotein particles","volume":"21","author":"Blanchette","year":"2010","journal-title":"Bioconjug Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/bc8003155","article-title":"Immobilization of His-tagged proteins on nickel-chelating nanolipoprotein particles","volume":"20","author":"Fischer","year":"2009","journal-title":"Bioconjug Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1128\/IAI.00070-07","article-title":"Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge","volume":"75","author":"Bielinska","year":"2007","journal-title":"Infect Immun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.1016\/j.vaccine.2006.12.001","article-title":"Induction of secretory immunity and memory at mucosal surfaces","volume":"25","author":"Brandtzaeg","year":"2007","journal-title":"Vaccine."},{"key":"B39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev-immunol-032414-112315","article-title":"Exploiting mucosal immunity for antiviral vaccines","volume":"34","author":"Iwasaki","year":"2016","journal-title":"Annu Rev Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1021\/bk-2017-1271.ch006","article-title":"Strategies for functionalizing lipoprotein-based nanoparticles. In control of amphiphile self-assembling at the molecular level: supra-molecular assemblies with tuned physicochemical properties for delivery applications","volume":"1271","author":"Gilmore","year":"2017","journal-title":"ACS Symp Ser"},{"key":"B41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1365-2958.2000.03000.x","article-title":"A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium","volume":"45","author":"Sylvestre","year":"2002","journal-title":"Mol Microbiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fimmu.2013.00185","article-title":"Multi-faceted functions of secretory IgA at mucosal surfaces","volume":"4","author":"Corth\u00e9sy","year":"2013","journal-title":"Front Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.4049\/jimmunol.178.5.2646","article-title":"Cutting Edge: IFN-\u03b3-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis","volume":"178","author":"Glomski","year":"2007","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1128\/JB.00762-07","article-title":"The BclB glycoprotein of Bacillus anthracis is involved in exosporium integrity","volume":"189","author":"Thompson","year":"2007","journal-title":"J Bacteriol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1365-2958.2007.05658.x","article-title":"Non-uniform assembly of the Bacillus anthracis exosporium and a bottle cap model for spore germination and outgrowth","volume":"64","author":"Steichen","year":"2007","journal-title":"Mol Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"7587","DOI":"10.1128\/JB.01110-09","article-title":"Roles of the Bacillus anthracis spore protein ExsK in exosporium maturation and germination","volume":"191","author":"Severson","year":"2009","journal-title":"J Bacteriol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1128\/JB.187.17.5868-5876.2005","article-title":"Characterization of the exosporium basal layer protein BxpB of Bacillus anthracis","volume":"187","author":"Steichen","year":"2005","journal-title":"J Bacteriol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1128\/JB.186.2.566-569.2004","article-title":"Surface layer protein EA1 is not a component of Bacillus anthracis spores but is a persistent contaminant in spore preparations","volume":"186","author":"Williams","year":"2004","journal-title":"J Bacteriol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1574-6968.2008.01380.x","article-title":"Characterization of a Bacillus anthracis spore coat-surface protein that influences coat-surface morphology","volume":"289","author":"Mallozzi","year":"2008","journal-title":"FEMS Microbiol Lett."},{"key":"B51","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1128\/JB.00921-06","article-title":"Morphogenesis of the Bacillus anthracis spore","volume":"189","author":"Giorno","year":"2007","journal-title":"J Bacteriol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1099\/0022-1317-51-10-821","article-title":"In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody","volume":"51","author":"Welkos","year":"2002","journal-title":"J Med Microbiol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01264\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T05:35:12Z","timestamp":1592890512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01264\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2020.01264"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01264","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"article-number":"1264"}}